hydroxyproline has been researched along with Fatty Liver, Nonalcoholic in 7 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Inflammation and fibrosis were evaluated by transaminases, myeloperoxidase activity, hydroxyproline, and histological evaluation." | 4.12 | Chronic intermittent hypoxia promotes early intrahepatic endothelial impairment in rats with nonalcoholic fatty liver disease. ( Abrante, B; Abreu-González, P; de la Barreda, R; Díaz-Flores, F; González-Paredes, FJ; Hernández-Bustabad, A; Hernández-Guerra, M; Morales-Arraez, D; Quintero, E, 2022) |
| "Nonalcoholic fatty liver disease (NAFLD), a hepatic characteristic of metabolic syndrome, received significant attention in clinical settings." | 1.72 | Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice. ( Aizawa, K; Arai, N; Iwamoto, S; Maeda, H; Miura, K; Morimoto, N; Nagayama, M; Sakamoto, H; Sekiya, M; Yamamoto, H, 2022) |
| "Characteristics of nonalcoholic steatohepatitis-related liver fibrosis in KO-MCD/HF group were verified by hepatic histological analyses." | 1.56 | CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease. ( Jiang, Q; Li, G; Liu, B; Xu, K; Zhang, J, 2020) |
| "Early detection and accurate staging of liver fibrosis is critically important for patient management." | 1.51 | Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH). ( Boominathan, R; Cheng, P; Chong, YC; Deng, X; Goggi, JL; Han, W; Hartimath, SV; Robins, EG; Soh, V; Tan, PW; Yong, FF, 2019) |
| "Ipragliflozin is a selective sodium glucose cotransporter 2 (SGLT2) inhibitor that increases urinary glucose excretion by inhibiting renal glucose reabsorption and thereby causes a subsequent antihyperglycemic effect." | 1.42 | Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats. ( Hayashizaki-Someya, Y; Koide, K; Kurosaki, E; Mitori, H; Takakura, S; Takasu, T; Yamazaki, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, AD | 1 |
| Kim, SE | 1 |
| Leszczynska, A | 1 |
| Kaufmann, B | 1 |
| Reca, A | 1 |
| Kim, DJ | 1 |
| Feldstein, AE | 1 |
| Hernández-Bustabad, A | 1 |
| Morales-Arraez, D | 1 |
| González-Paredes, FJ | 1 |
| Abrante, B | 1 |
| Díaz-Flores, F | 1 |
| Abreu-González, P | 1 |
| de la Barreda, R | 1 |
| Quintero, E | 1 |
| Hernández-Guerra, M | 1 |
| Arai, N | 1 |
| Miura, K | 1 |
| Aizawa, K | 1 |
| Sekiya, M | 1 |
| Nagayama, M | 1 |
| Sakamoto, H | 1 |
| Maeda, H | 1 |
| Morimoto, N | 1 |
| Iwamoto, S | 1 |
| Yamamoto, H | 1 |
| Hartimath, SV | 1 |
| Boominathan, R | 1 |
| Soh, V | 1 |
| Cheng, P | 1 |
| Deng, X | 1 |
| Chong, YC | 1 |
| Yong, FF | 1 |
| Tan, PW | 1 |
| Han, W | 1 |
| Robins, EG | 1 |
| Goggi, JL | 1 |
| Li, G | 1 |
| Zhang, J | 1 |
| Jiang, Q | 1 |
| Liu, B | 1 |
| Xu, K | 1 |
| Yang, HY | 1 |
| Yeh, WJ | 1 |
| Ko, J | 1 |
| Chen, JR | 1 |
| Hayashizaki-Someya, Y | 1 |
| Kurosaki, E | 1 |
| Takasu, T | 1 |
| Mitori, H | 1 |
| Yamazaki, S | 1 |
| Koide, K | 1 |
| Takakura, S | 1 |
7 other studies available for hydroxyproline and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis.
Topics: Animals; Cytokines; Diet, High-Fat; Disease Models, Animal; Fructose; Hydroxyproline; Liver; Liver C | 2021 |
Chronic intermittent hypoxia promotes early intrahepatic endothelial impairment in rats with nonalcoholic fatty liver disease.
Topics: Acetaminophen; Acetylcholine; Animals; Hydroxyproline; Hypoxia; Inflammation; Intercellular Adhesion | 2022 |
Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cytokines; Fibrosis; Glutathione; Hepatocytes; H | 2022 |
Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Topics: Actins; Animals; Choline Deficiency; Collagen; Diet, High-Fat; Disease Progression; Early Diagnosis; | 2019 |
CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Choline Deficiency; Cyclic AMP Response Element-Binding Protein; Diet | 2020 |
Camellia oleifera seed extract attenuated abdominal and hepatic fat accumulation in rats fed a high-fat diet.
Topics: Alanine Transaminase; Animals; Body Weight; Camellia; Diet, High-Fat; Hydroxyproline; Intra-Abdomina | 2019 |
Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.
Topics: Amino Acids; Animals; Choline Deficiency; Food, Formulated; Glucosides; Hydroxyproline; Hypoglycemic | 2015 |